- Home
- BRNS vs VATE Comparison
BRNS vs VATE Comparison
Compare BRNS & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- VATE
- Stock Information
- Founded
- BRNS 2016
- VATE 1994
- Country
- BRNS United Kingdom
- VATE United States
- Employees
- BRNS N/A
- VATE N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- BRNS Health Care
- VATE Industrials
- Exchange
- BRNS Nasdaq
- VATE Nasdaq
- Market Cap
- BRNS 52.0M
- VATE 49.2M
- IPO Year
- BRNS 2021
- VATE 1996
- Fundamental
- Price
- BRNS $1.17
- VATE $5.36
- Analyst Decision
- BRNS Strong Buy
- VATE
- Analyst Count
- BRNS 2
- VATE 0
- Target Price
- BRNS $4.00
- VATE N/A
- AVG Volume (30 Days)
- BRNS 39.3K
- VATE 91.3K
- Earning Date
- BRNS 11-07-2024
- VATE 11-07-2024
- Dividend Yield
- BRNS N/A
- VATE N/A
- EPS Growth
- BRNS N/A
- VATE N/A
- EPS
- BRNS N/A
- VATE N/A
- Revenue
- BRNS N/A
- VATE $1,364,600,000.00
- Revenue This Year
- BRNS $27.18
- VATE N/A
- Revenue Next Year
- BRNS N/A
- VATE N/A
- P/E Ratio
- BRNS N/A
- VATE N/A
- Revenue Growth
- BRNS N/A
- VATE N/A
- 52 Week Low
- BRNS $1.11
- VATE $3.25
- 52 Week High
- BRNS $5.10
- VATE $15.50
- Technical
- Relative Strength Index (RSI)
- BRNS 40.45
- VATE 72.35
- Support Level
- BRNS $1.15
- VATE $3.25
- Resistance Level
- BRNS $1.35
- VATE $4.16
- Average True Range (ATR)
- BRNS 0.07
- VATE 0.33
- MACD
- BRNS 0.00
- VATE 0.19
- Stochastic Oscillator
- BRNS 14.29
- VATE 96.35
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.